Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization

被引:19
|
作者
Sinha, Neelima [1 ]
Karche, Navnath P. [1 ]
Verma, Mahip Kalyan [1 ]
Walunj, Sameer S. [1 ]
Nigade, Prashant B. [1 ]
Jana, Gourhari [1 ]
Kurhade, Sanjay P. [1 ]
Hajare, Anil K. [1 ]
Tilekar, Ajay R. [1 ]
Jadhav, Ganesh R. [1 ]
Thube, Baban R. [1 ]
Shaikh, Javed S. [1 ]
Balgude, Sudhakar [1 ]
Singh, Lairikyengbam Bikramjit [1 ]
Mahimane, Vijaya [1 ]
Adurkar, Shridhar K. [1 ]
Hatnapure, Girish [1 ]
Raje, Firoj [1 ]
Bhosale, Yogesh [1 ]
Bhanage, Dnyaneshwar [1 ]
Sachchidanand, Sachchidanand [1 ]
Dixit, Ruchi [1 ]
Gupta, Rajesh [1 ]
Bokare, Anand M. [1 ]
Dandekar, Manoj [1 ]
Bharne, Ashish [1 ]
Chatterjee, Manavi [1 ]
Desai, Sagar [1 ]
Koul, Sarita [1 ]
Modi, Dipak [1 ]
Mehta, Maneesh [1 ]
Patil, Vinod [1 ]
Singh, Minakshi [1 ]
Gundu, Jayasagar [1 ]
Goel, Rajan N. [1 ]
Shah, Chirag [1 ]
Sharma, Sharad [1 ]
Bakhle, Dhananjay [1 ]
Kamboj, Rajender Kumar [1 ]
Palle, Venkata P. [1 ]
机构
[1] Lupin Ltd, Lupin Res Pk, Novel Drug Discovery & Dev, Survey 46 A-47 A, Pune 412115, Maharashtra, India
关键词
COGNITIVE IMPAIRMENT; PARTIAL AGONIST; SCHIZOPHRENIA; TRANSMISSION; SELECTIVITY; ACTIVATION; EVP-6124; RODENTS; SAFETY; MEMORY;
D O I
10.1021/acs.jmedchem.9b01569
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery of a series of thiophenephenyl-sulfonamides as positive allosteric modulators (PAM) of alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR) is described. Optimization of this series led to identification of compound 28, a novel PAM of alpha 7 nicotinic acetylcholine receptor (alpha 7 nAChR). Compound 28 showed good in vitro potency, with pharmacokinetic profile across species with excellent brain penetration and residence time. Compound 28 robustly reversed the cognitive deficits in episodic/working memory in both time-delay and scopolamine-induced amnesia paradigms in the novel object and social recognition tasks, at very low dose levels. Additionally, compound 28 has shown excellent safety profile in phase 1 clinical trials and is being evaluated for efficacy and safety as monotherapy in patients with mild to moderate Alzheimer's disease.
引用
收藏
页码:944 / 960
页数:17
相关论文
共 7 条
  • [1] Discovery of 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
    Faghih, Ramin
    Gopalakrishnan, Sujatha M.
    Gronlien, Jens Halvard
    Malysz, John
    Briggs, Clark A.
    Wetterstrand, Caroline
    Ween, Hilde
    Curtis, Michael P.
    Sarris, Kathy A.
    Gfesser, Gregory A.
    El-Kouhen, Rachid
    Robb, Holly M.
    Radek, Richard J.
    Marsh, Kennan C.
    Bunnelle, William H.
    Gopalakrishnan, Murali
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (10) : 3377 - 3384
  • [2] Characterization of 2-[[4-Fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
    Dinklo, Theo
    Shaban, Hamdy
    Thuring, Jan Willem
    Lavreysen, Hilde
    Stevens, Karen E.
    Zheng, Lijun
    Mackie, Claire
    Grantham, Christopher
    Vandenberk, Ine
    Meulders, Greet
    Peeters, Luc
    Verachtert, Hanne
    De Prins, Erik
    Lesage, Anne S. J.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 336 (02): : 560 - 574
  • [3] Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789)
    Zanaletti, Riccardo
    Bettinetti, Laura
    Castaldo, Cristiana
    Cocconcelli, Giuseppe
    Comery, Thomas
    Dunlop, John
    Gaviraghi, Giovanni
    Ghiron, Chiara
    Haydar, Simon N.
    Jow, Flora
    Maccari, Laura
    Micco, Iolanda
    Nencini, Arianna
    Scali, Carla
    Turlizzi, Elisa
    Valacchit, Michela
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) : 4806 - 4823
  • [4] Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator
    Hao, Junliang
    Dehlinger, Veronique
    Fivush, Adam M.
    Rudyk, Helene C. E.
    Britton, Thomas C.
    Hollinshead, Sean P.
    Vokits, Benjamin P.
    Clark, Barry P.
    Henry, Steven S.
    Massey, Steven M.
    Peng, Langu
    Dressman, Bruce A.
    Heinz, Beverly A.
    Roberts, Edda F.
    Bracey-Walker, Mallorie R.
    Swanson, Steven
    Catlow, John T.
    Love, Patrick L.
    Tepool, Anita D.
    Peters, Steven C.
    Simmons, Rosa Maria A.
    Iyengar, Smriti
    McKinzie, David L.
    Monn, James A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (05) : 1249 - 1252
  • [5] Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM)
    Maria Cid, Jose
    Tresadern, Gary
    Antonio Vega, Juan
    Isabel de Lucas, Ana
    del Cerro, Alcira
    Matesanz, Encamacion
    Lourdes Linares, Maria
    Garcia, Aranzazu
    Ituttrino, Laura
    Perez-Benito, Laura
    Macdonald, Gregor J.
    Oehlrich, Daniel
    Lavreysen, Hilde
    Peeters, Luc
    Ceusters, Marc
    Ahnaou, Abdellah
    Drinkenburg, Wilhelmus
    Mackie, Claire
    Somers, Marijke
    Trabanco, Andres A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (18) : 8495 - 8507
  • [6] Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1H-Pyrazolo[4,3-b]pyridin-3-yl)amino)-benzo[d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu4)
    Bollinger, Sean R.
    Engers, Darren W.
    Panarese, Joseph D.
    West, Mary
    Engers, Julie L.
    Loch, Matthew T.
    Rodriguez, Alice L.
    Blobaum, Anna L.
    Jones, Carrie K.
    Gray, Analisa Thompson
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Niswender, Colleen M.
    Hopkins, Corey R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (01) : 342 - 358
  • [7] Structure-Activity Relationship Studies and Discovery of a Potent Transient Receptor Potential Vanilloid (TRPV1) Antagonist 4-[3-Chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517) as a Clinical Candidate for Pain Management
    Tafesse, Laykea
    Kanemasa, Toshiyuki
    Kurose, Noriyuki
    Yu, Jianming
    Asaki, Toshiyuki
    Wu, Gang
    Iwamoto, Yuka
    Yamaguchi, Yoshitaka
    Ni, Chiyou
    Engel, John
    Tsuno, Naoki
    Patel, Aniket
    Zhou, Xiaoming
    Shintani, Takuya
    Brown, Kevin
    Hasegawa, Tsuyoshi
    Shet, Manjunath
    Iso, Yasuyoshi
    Kato, Akira
    Kyle, Donald J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (15) : 6781 - 6794